News Column

BIOCRYST PHARMACEUTICALS INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

June 3, 2014

Item 8.01. Other Events.

On May 28, 2014, the Company entered into an underwriting agreement (the "Underwriting Agreement") with J. P. Morgan Securities LLC, as representative of the underwriters named in Schedule 1 thereto (the "Underwriters"), with respect to the issuance and sale in an underwritten public offering (the "Offering") by the Company of 10,000,000 shares of the Company's common stock at a price to the public of $10.00 per share. Pursuant to the Underwriting Agreement, the Company also granted the underwriters a 30-day option (the "Underwriters' Option") to purchase up to an additional 1,500,000 shares of the Company's common stock. On May 29, 2014, the Underwriters exercised the Underwriters' Option in full.

The shares issuable in the Offering, including the Underwriters' Option, have been registered under the Securities Act of 1933 (the "Securities Act") pursuant to a registration statement on Form S-3 (Registration No. 333-192117) of the Company (the "Registration Statement"), and a prospectus supplement dated May 28, 2014, was filed with the Securities and Exchange Commission pursuant to Rule 424(b) of the Securities Act on May 29, 2014. The closing of the Offering, including the shares issuable pursuant to the Underwriters' Option, is expected to occur on June 3, 2014. The legal opinion of Gibson, Dunn & Crutcher LLP relating to the Registration Statement is filed herewith as Exhibit 5.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated May 28, 2014, by and between BioCryst Pharmaceuticals, Inc., and J.P. Morgan Securities LLC, as representative of the underwriters named in Schedule 1 thereto. 5.1 Opinion of Gibson, Dunn & Crutcher LLP.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters